These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 679460)

  • 41. Considerations for the programming of an open-loop insulin infusion device from the biostator glucose controller.
    Service FJ; Rizza RA; Westland RE; Hall LD; Nelson RL; Haymond MW; Clemens AH; Gerich JE
    Diabetes Care; 1980; 3(2):278-84. PubMed ID: 6993141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Feasibility and reproductibility of a euglycemic hyperinsulinic glucose clamp technic].
    Gin H; Brunel PG; Brottier E; Aubertin J; Drouin P; Debry G
    Diabete Metab; 1984 Jan; 10(1):36-8. PubMed ID: 6373424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significance of renormalization of blood glucose concentration in diabetes mellitus.
    Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):2-8. PubMed ID: 395080
    [No Abstract]   [Full Text] [Related]  

  • 44. Metabolic effects of pulsatile insulin infusion in the elderly.
    Paolisso G; Salvatore T; Sgambato S; Torella R; Varricchio M; D'Onofrio F
    Acta Endocrinol (Copenh); 1990 Jul; 123(1):19-23. PubMed ID: 1975147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.
    Cline GW; Petersen KF; Krssak M; Shen J; Hundal RS; Trajanoski Z; Inzucchi S; Dresner A; Rothman DL; Shulman GI
    N Engl J Med; 1999 Jul; 341(4):240-6. PubMed ID: 10413736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of peripheral plasma somatostatin like immunoreactivity in type I diabetes: role of the degree of metabolic control.
    Beylot M; Chayvialle JA; Rebattu B; Sautot G; Cohen R; Riou JP; Mornex R
    Diabete Metab; 1986 Feb; 12(1):39-44. PubMed ID: 3516750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initial distribution volume of glucose can be approximated using a conventional glucose analyzer in the intensive care unit.
    Ishihara H; Nakamura H; Okawa H; Takase H; Tsubo T; Hirota K
    Crit Care; 2005 Apr; 9(2):R144-9. PubMed ID: 15774047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diurnal rhythm of insulin sensitivity in subjects with normal and impaired glucose tolerance.
    Schulz B; Ratzmann KP; Albrecht G; Bibergeil H
    Exp Clin Endocrinol; 1983 May; 81(3):263-72. PubMed ID: 6350027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enzyme-coupled ultraviolet determination of alpha-amylase activity with the GEMSAEC centrifugal analyzer.
    Porter WH; Roberts RE
    Clin Chem; 1978 Sep; 24(9):1620-4. PubMed ID: 357041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measurement of glucose in plasma, with use of immobilized glucose oxidase and peroxidase.
    Kiang SW; Kuan JW; Kuan SS; Guilbault GG
    Clin Chem; 1976 Aug; 22(8):1378-82. PubMed ID: 949848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic studies during normoglycaemic clamping of insulin-dependent diabetics using a glucose-controlled insulin infusion system.
    Nattrass M; Alberti KG; Buckle AL; Cluett B; Jaspan JB; Noy GA; Stubbs WA; Walton R
    Horm Metab Res Suppl; 1979; (8):86-92. PubMed ID: 395096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The determination of capillary blood glucose using the automatic clinical analyzer (aca) Dupont (author's transl)].
    Heinemann G
    J Clin Chem Clin Biochem; 1978 Apr; 16(4):235-8. PubMed ID: 641450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic responses to intraduodenal glucose loading in insulin-infused diabetic dogs.
    Stevenson RW; Orskov H; Parsons JA; Alberti KG
    Am J Physiol; 1983 Aug; 245(2):E200-8. PubMed ID: 6349384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus.
    Perriello G; De Feo P; Torlone E; Calcinaro F; Ventura MM; Basta G; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    N Engl J Med; 1988 Nov; 319(19):1233-9. PubMed ID: 3054544
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
    Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J
    Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial betacell and during conventional therapy.
    Christiansen JS; Svendsen PA; Mathiesen E; Rubin P; Deckert T
    Horm Metab Res; 1981 Oct; 13(10):537-41. PubMed ID: 7028586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system).
    Pfeiffer EF; Thum C; Clemens AH
    Horm Metab Res; 1974 Sep; 6(5):339-42. PubMed ID: 4607598
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluation of the Abbott Bichromatic Analyzer 100 (A proposal for an evaluation scheme).
    Haeckel R
    J Clin Chem Clin Biochem; 1976 May; 14(5):227-37. PubMed ID: 956729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics and biological activity of the new intermediate-acting insulin L-SNC).
    Schulz B; Menzel R; Ratzmann KP; Heinke P
    Exp Clin Endocrinol; 1987 Dec; 90(3):278-84. PubMed ID: 3330036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Semisynthetic human insulin: pharmacokinetics and biological potency in healthy subjects in comparison with highly purified porcine insulin.
    Schulz B; Stöwhas H; Becker R; Steinicke A; Besch W
    Exp Clin Endocrinol; 1988 Mar; 92(3):307-13. PubMed ID: 3075554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.